Yolanda Macias
About Yolanda Macias
Yolanda Macías, 60, is Cineverse’s Chief Motion Pictures Officer, elevated in 2025 to lead global motion picture rights acquisition and the exhibitor, marketing, sales, and operations teams for theatrical releases; she joined Cineverse in 2013 after senior roles at Vivendi/Universal (2004–2012), DIRECTV (1996–2003), and The Walt Disney Company (1992–1995). She holds an MBA from Northwestern’s Kellogg School and a B.S. in Finance from CSU Northridge; she also served on the Skechers USA board until its September 2025 take-private and is Vice Chair for C5LA . Company performance context during the most recent fiscal year: FY2025 revenue rose 59% to $78.2M vs. $49.1M in FY2024 and net income improved to $3.8M; TSR measured on the SEC “Pay vs Performance” table moved from 4.16 (FY2024) to 19.51 (FY2025) for a $100 initial value reference .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Vivendi/Universal | Executive positions | 2004–2012 | Led entertainment distribution initiatives; broad studio partnerships and rights acquisition experience . |
| DIRECTV | Executive positions | 1996–2003 | Built premium content distribution strategies for pay TV; strengthened licensing and sales channels . |
| The Walt Disney Company | Executive positions | 1992–1995 | Contributed to studio distribution operations and market development . |
External Roles
| Organization | Role | Years | Impact |
|---|---|---|---|
| Skechers USA, Inc. (NYSE: SKX) | Director | Until Sept 2025 | Corporate governance and consumer brand oversight; board service ended with private equity transaction . |
| C5LA | Vice Chair | Ongoing | Non-profit leadership supporting high-potential youth; community and talent pipeline engagement . |
Fixed Compensation
- Macias is an executive officer but is not listed among the Named Executive Officers (NEOs) in the latest proxy; individual base salary, target bonus, and perquisites are not disclosed for her in the DEF 14A .
- Cineverse administers annual incentives via the MAIP and long-term equity under the 2017 Equity Incentive Plan; these program structures apply broadly but specific Macias grant terms are not itemized in the proxy .
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Not disclosed for Macias | — | — | — | — | — |
- Company-wide programs: MAIP bonuses are set against the approved financial plan and key performance metrics; payouts may be in cash or stock and are approved by the Compensation Committee . Equity awards (RSUs/PSUs/SARs) under the 2017 Plan are subject to minimum one‑year vesting and may include performance objectives across revenue growth, EBITDA/earnings, margins, TSR, market share and strategic milestones, at the Committee’s discretion .
Equity Ownership & Alignment
| Date | Filing/Type | Shares (Units) | Price | Nature/Notes |
|---|---|---|---|---|
| Nov 6, 2023 | Form 3 (CNVS) | 0 | — | Initial filing indicates reporting status; no initial holdings reported . |
| Apr 25, 2024 (reported Apr 26) | Form 4 Grant (CNVS) | 100,000 | — | Equity grant (RSUs/restricted stock); aligns with company equity-heavy incentives . |
| Apr 4, 2025 | Disposition (Non Open Market) (CNVS) | 36,680 | $3.00 | Non-open market disposition (commonly tax withholding); reported direct holding post-transaction 93,949 shares . |
| Oct 8, 2025 | Acquisition (CNVS) | 79,879 | — | Reported acquisition in third-party ownership feed; consistent with 2025 executive equity grants . |
| Oct 10, 2025 | Form 4 filed (CNVS) | Multiple changes | — | Statement of changes in beneficial ownership consistent with fall 2025 grants . |
- Insider policy restricts speculative transactions (short sales) and discourages hedging; pre-clearance is required for all equity transactions. No pledging is disclosed for Macias, and the company’s clawback policy complies with Dodd‑Frank Section 954 and Nasdaq listing standards .
- Beneficial ownership detail for Macias is not in the DEF 14A table (NEO/Director table does not include her); holdings are instead visible via Form 4 and third-party insider feeds cited above .
Employment Terms
- No individual employment agreement for Macias is filed in the cited period; severance, bonus targets, and change‑of‑control cash multiples disclosed for other executives are not available for Macias .
- 2017 Equity Incentive Plan provisions: minimum one‑year vesting; broad performance objective menu; change‑of‑control treatment includes immediate vesting/settlement when no Replacement Award is issued and pro‑rata vesting for unearned performance awards at the higher of actual or target; no tax gross‑ups and clawback applies .
Performance & Track Record
| Metric | FY2024 | FY2025 | Commentary |
|---|---|---|---|
| Total Revenue ($000) | 49,131 | 78,181 | +59% y/y; driven by Terrifier 3 theatrical and improved streaming/digital licensing . |
| Net Income ($000) | (21,265) | 3,764 | Profitability inflection; cash from ops $17.4M FY2025 . |
| TSR ($ initial $100 reference) | 4.16 | 19.51 | Company TSR (SEC PVP table), indicative of shareholder outcome across FY2024–FY2025 . |
- Division outcomes under her leadership: management reorganized film division with Macias as Chief Motion Pictures Officer to scale a slate leveraging the Terrifier blueprint; slate includes Toxic Avenger (Aug 29, 2025), Silent Night, Deadly Night (Dec 12, 2025), Return to Silent Hill (Jan 23, 2026), Wolf Creek: Legacy (2026) .
- Strategic win: Cineverse secured North American rights to Guillermo del Toro’s Pan’s Labyrinth for 2026 re‑release; Macias led the negotiation, with a premium theatrical format and multi‑platform distribution planned ******]** (embedded content via press release indexed as 11/05/2025) .
Board Governance (Company-level context)
- Compensation Committee: independent directors; chaired by Mary Ann Halford; uses Aon as compensation consultant; committee meets and approves executive pay structures and grants .
- Say-on-Pay feedback: investor engagement after 2023’s 62% approval led to improved transparency and 90% approval in 2024 .
Compensation Committee Analysis
- The committee emphasizes pay‑for‑performance with balanced cash and equity, performance targets, vesting provisions, and clawbacks; Aon engaged to guide design and levels .
- No executive tax gross‑ups under equity plan; no option/SAR repricing without shareholder approval .
Investment Implications
- Alignment: Frequent equity grants to Macias (Apr 2024, Oct 2025) indicate strong at‑risk pay tied to long‑term value creation; non‑open market dispositions suggest routine tax withholding rather than active selling pressure .
- Retention risk: Absence of filed individual severance/change‑of‑control terms for Macias lowers visibility into retention economics; however, plan-level CIC equity acceleration provides retention value in strategic transactions .
- Trading signals: Limited disclosed selling activity and policy restrictions on speculative trades/hedging reduce misalignment risk; continuing grants and larger film slate under Macias point to execution leverage on revenue and earnings trajectory .
- Governance: Company’s improved say‑on‑pay support and clawback compliance mitigate compensation red flags; no related party transactions reported .
Note: Where Cineverse’s DEF 14A does not disclose Macias-specific compensation or employment agreement details, company-level policies and plan terms are cited. Individual insider transaction details are sourced from SEC-oriented third-party trackers with full URLs as provided above.